Skip to main content

Trulance News

Synergy Pharmaceuticals Announces FDA Approval of Trulance (plecanatide) for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults

NEW YORK--(BUSINESS WIRE) January 25, 2018 – Synergy Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Trulance (plecanatide) 3 mg tablet for the...

FDA Approves Trulance (plecanatide) for Chronic Idiopathic Constipation

January 19, 2017 – The U.S. Food and Drug Administration today approved Trulance (plecanatide) for the treatment of Chronic Idiopathic Constipation (CIC) in adult patients. “No one medication works f...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Trulance patient information at Drugs.com